AS101 1% oral solution
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AS101 1% oral solution, covering 2020-11-04 to 2020-11-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD) [Phase 1, Phase 2]